Definitive Contract 75F40122C00138
- Not listed
- This is a $1,062,186 firm fixed-price definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency under the Department of Health and Human Services, to the University of Southern California (USC) Department of Contracts and Grants Division. The contract does not have a set-aside designation. USC, a leading private research university, is providing services related to the contract's ultimate completion date of September 24, 2017. As a prime contractor with...
- This is a firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the University of Southern California (USC) for $249,478.00 to characterize the efficacy of azithromycin against carbapenem-resistant gram-negative bacteria in bicarbonate-containing culture media. The contract does not have a set-aside designation and has a completion date of December 31, 2024. USC is a well-established private research university that regularly performs work for the federal government...
- This is a federal contract awarded by the Office of Procurement Operations (OPO), a civilian agency, to the University of Southern California (USC) Department of Contracts and Grants Division. The contract, valued at $800,000.00, is a Definitive Contract with a Cost No Fee pricing type and does not have a set-aside designation. The contract is part of the Major Program Code "RETRO-FUTURE BRIDGE AND OUTAGES" and has an ultimate completion date of April 19, 2018. USC, a leading private...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Southern California (USC) with a potential value of $2,249,507.99. The contract is for a preclinical mouse model of Acinetobacter baumannii infection to support antibacterial drug development. USC is the prime contractor, and Case Western Reserve University and the University of Florida are major subcontractors supporting this research effort. The contract does...
- This is a $75,000.00 Firm Fixed Price Purchase Order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Southern California (USC) for SPECIAL STUDIES - REGULATORY IMPACT ANALYSIS. The contract has no set-aside designation. USC is a leading private research university that frequently collaborates with federal agencies on research and development activities across various disciplines. In addition to this contract, USC holds several Indefinite Delivery Vehicle...
- This is a firm-fixed price purchase order contract awarded by the U.S. Army Corps of Engineers to the University of Southern California (USC) for work related to the Coronavirus COVID-19 national interest action. The contract has a potential value of $200,000.00 and a completion date of August 26, 2021. The contract was not set aside for small businesses. USC is a private university that has extensive experience performing a variety of research and service contracts for federal agencies such...
- The Department of Health and Human Services Food and Drug Administration awarded a $150,000.00 firm-fixed-price definitive contract to the University of Southern California (USC) Dept of Contracts and Grants for the Implementation of Real Time Application for Portable Interactive Devices (RAPID) Blockchain. This contract does not have a set-aside designation. USC is a private university that has previously provided the government with a variety of goods and services, including aviation safety...
- This is a $150,000 firm fixed-price delivery order contract awarded to the University of Southern California (USC) by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The contract is for COVID-19 non-vaccine countermeasure adverse effects research, with a period of performance ending on January 12, 2024. USC has extensive experience conducting federal research and development across a wide range of disciplines, including biomedical research, cybersecurity, and...
- This is a federal contract award to the University of Southern California (USC) by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The contract has a ceiling value of $520,000.00 and is for a project titled "Outcomes of Alternative Payment Models". The contract does not have a set-aside designation. USC is the prime contractor and will be performing the work at a location in Dockweiler, CA. The contract is a Delivery Order with a Firm Fixed Price...
- This is a definitive contract awarded by the Defense Health Agency (DHA) to the University of Southern California (USC) on September 6, 2016. The contract has a ceiling value of $3,292,634.88 and an ultimate completion date of January 31, 2022. The contract is not set aside for any specific business type. The contract provides for a range of research, scientific, technological, and educational services that leverage USC's expertise across engineering, health sciences, computer science, and other...
The University of Southern California Department of Contracts and Grants Division, doing business as USC, has been awarded a $246,617 definitive cost-no-fee contract by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to conduct a study on modified susceptibility testing protocols for predicting the in vivo efficacy of polymyxins. Performance will take place in Silver Spring, Maryland over a period of approximately 18 months concluding in March 2024. The contract is associated with BAA-PMWP#198 issued by HHS FDA to develop new methods and data to support the agency's regulatory review of antimicrobial drugs. As the prime contractor, USC will likely utilize subcontractors to assist with research activities under this contract to help HHS FDA advance its evaluation of polymyxin antibiotics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 12/11/23 | |
| P00002 | Other Administrative Action | $0 | 9/1/23 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 10/20/22 | |
| Not listed | Not listed | $246.6k | 9/22/22 |